This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Aripiprazole

Read time: 1 mins
Marketing start date: 18 Nov 2024
...
 

Summary of product characteristics


Effective Time

20230920

Version

5

Spl Product Data Elements

Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE PEPPERMINT MANNITOL WHITE TO OFF-WHITE FLAVOR FIRMENICH POWDER PEPPERMINT BARREL ZE;13 Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE PEPPERMINT MANNITOL WHITE TO OFF-WHITE FLAVOR FIRMENICH POWDER PEPPERMINT CAPSULE ZE;4 Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE PEPPERMINT MANNITOL WHITE TO OFF-WHITE FLAVOR FIRMENICH POWDER PEPPERMINT ROUND ZE;14 Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE PEPPERMINT MANNITOL WHITE TO OFF-WHITE FLAVOR FIRMENICH POWDER PEPPERMINT BARREL ZE;15 Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE PEPPERMINT MANNITOL WHITE TO OFF-WHITE FLAVOR FIRMENICH POWDER PEPPERMINT ROUND ZE;16 Aripiprazole Aripiprazole ARIPIPRAZOLE ARIPIPRAZOLE ASPARTAME CALCIUM STEARATE CROSPOVIDONE MANNITOL WHITE TO OFF-WHITE CAPSULE L1

Application Number

ANDA090472

Brand Name

Aripiprazole

Generic Name

Aripiprazole

Product Ndc

70771-1453

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1451-1 Aripiprazole Tablets, 2 mg 100 tablets Rx only NDC 70771-1452-1 Aripiprazole Tablets, 5 mg 100 tablets Rx only NDC 70771-1453-9 Aripiprazole Tablets, 10 mg 90 tablets Rx only NDC 70771-1454-9 Aripiprazole Tablets, 15 mg 90 tablets Rx only NDC 70771-1455-9 Aripiprazole Tablets, 20 mg 90 tablets Rx only NDC 70771-1456-9 Aripiprazole Tablets, 30 mg 90 tablets Rx only Aripiprazole Tablets Aripiprazole Tablets Aripiprazole Tablets Aripiprazole Tablets Aripiprazole Tablets Aripiprazole Tablets

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.